Medicare Enrolled

Dr. Harry Sarles, M.D.

Gastroenterology · Rockwall, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
3144 HORIZON RD STE 210, Rockwall, TX 75032
9727712222
In practice since 2006 (20 years)
NPI: 1861451395 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sarles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sarles? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sarles

Dr. Harry Sarles is a gastroenterology in Rockwall, TX, with 20 years in practice. Based on federal Medicare data, Dr. Sarles performed 617 Medicare services across 598 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sarles received a total of $66,037 from 51 pharmaceutical and/or device companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sarles is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 50% volume in TX$ $66,037 industry payments

Medicare Practice Summary

Medicare Utilization ↗
617
Medicare services
Top 50% in TX for gastroenterology
598
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~31 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Removal of polyps or growths of large bowel using an endoscope with mechanical snare186$198$1,067
Upper GI endoscopy with biopsy116$68$680
Office visit, established patient (20-29 min)75$61$148
Dilation of esophagus46$30$334
Colorectal cancer screening; colonoscopy on individual at high risk37$174$778
Colonoscopy with biopsy32$70$847
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk30$172$781
Office visit, established patient (30-39 min)20$83$217
Measurement of liver stiffness19$22$140
New patient office visit (45-59 min)17$104$332
New patient office or other outpatient visit, 15-29 minutes15$55$151
New patient office visit (30-44 min)13$81$219
Office visit, established patient (10-19 min)11$40$100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$66,037
Total received (2018-2024)
Avg $9,434/year across 7 years
Top 5% in TX for gastroenterology
51
Companies
672
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47,869 (72.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,641 (16.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,526 (11.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$46,210
2023
$6,304
2022
$2,060
2021
$2,207
2020
$2,943
2019
$4,296
2018
$2,015

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Phathom Pharmaceuticals, Inc.
$44,492
Regeneron Healthcare Solutions, Inc.
$2,862
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,558
E.R. Squibb & Sons, L.L.C.
$2,307
PFIZER INC.
$2,059
AbbVie Inc.
$2,058
ABBVIE INC.
$1,703
AbbVie, Inc.
$1,553
Takeda Pharmaceuticals U.S.A., Inc.
$1,191
Allergan Inc.
$733
Janssen Biotech, Inc.
$590
Janssen Scientific Affairs, LLC
$554
GENZYME CORPORATION
$403
Celgene Corporation
$387
Ferring Pharmaceuticals Inc.
$299
Amgen Inc.
$174
Ardelyx, Inc.
$156
Ironwood Pharmaceuticals, Inc
$144
Daiichi Sankyo Inc.
$132
VIVUS LLC
$128
RedHill Biopharma Inc.
$124
UCB, Inc.
$106
INTERCEPT PHARMACEUTICALS, INC.
$102
BOSTON SCIENTIFIC CORPORATION
$100
Boston Scientific Corporation
$99
Merck Sharp & Dohme Corporation
$91
Ethicon US, LLC
$91
IRONWOOD PHARMACEUTICALS, INC
$79
Nestle HealthCare Nutrition Inc.
$76
SHIELD THERAPEUTICS INC
$73
Intercept Pharmaceuticals, Inc.
$63
Lilly USA, LLC
$51
Merck Sharp & Dohme LLC
$43
Alfasigma USA, Inc.
$41
Gilead Sciences, Inc.
$39
Organon LLC
$39
Shire North American Group Inc
$35
Braintree Laboratories, Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
QOL Medical, LLC
$32
Medtronic, Inc.
$26
Ipsen Biopharmaceuticals, Inc
$25
Teva Pharmaceuticals USA, Inc.
$24
Pacira Pharmaceuticals Incorporated
$24
Synergy Pharmaceuticals Inc
$22
Endogastric Solutions, Inc
$20
Abbott Laboratories
$18
Covidien LP
$15
Shionogi Inc
$13
Allergan, Inc.
$11
Regeneron Pharmaceuticals, Inc.
$4
Top 3 companies account for 75.6% of total payments
Associated products mentioned in payments ›
ACCRUFER · AMJEVITA · APRISO · AVSOLA · Amitiza · Bylvay · CIMZIA · CLENPIQ · CREON · Cimzia · Confirm Rx · Creon · DIFICID · DUPIXENT · ENTYVIO · ESOPHYX · EXPAREL · Entyvio · GATTEX · GENERAL THERAPIES · GI Genius · HADLIMA · HUMIRA · Humira · IBSRELA · INFLECTRA · INJECTAFER · LINX Reflux Management System · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · Movantik · Mulpleta · NEXPOWDER · OCALIVA · Ozanimod · PANCREAZE · PREPOPIK · QSYMIA · REBYOTA · RENFLEXIS · RESOLUTION CLIP · RINVOQ · SKYRIZI · STELARA · SUPREP BOWEL PREP · SUTAB · Smart Pill · Sucraid · TREMFYA · TRULANCE · Talicia · Trulance · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for gastroenterology in TX.

Equivalent to $10,703 per 100 Medicare services performed
Looking for a gastroenterology in Rockwall?
Compare gastroenterologys in the Rockwall area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
152
Per 100K population
130.0
County median income
$124,917
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL ROCKWALL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sarles is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 5%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sarles experienced with removal of polyps or growths of large bowel using an endoscope with mechanical snare?
Based on Medicare claims data, Dr. Sarles performed 186 removal of polyps or growths of large bowel using an endoscope with mechanical snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sarles receive payments from pharmaceutical companies?
Yes. Dr. Sarles received a total of $66,037 from 51 companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sarles's costs compare to other gastroenterologys in Rockwall?
Dr. Sarles's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sarles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →